Schedule 13D ownership disclosure

Adamis Pharmaceuticals Corp

Security class unavailable · CUSIP: 00547W208

Event date: 2015-01-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,635,312
Percent of class
12.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-15-010366
Form type
SC 13D/A
Filer
DMK PHARMACEUTICALS Corp
CIK
CIK 887247
Filed
Feb 17, 2015
Reporting period
Jan 09, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub